SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-030942
Filing Date
2022-11-08
Accepted
2022-11-08 16:06:19
Documents
59
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 688085
2 ex10-1.htm EX-10.1 4119
3 ex31-1.htm EX-31.1 8022
4 ex31-2.htm EX-31.2 8008
5 ex32-1.htm EX-32.1 6619
6 ex10-1_001.jpg GRAPHIC 115078
7 ex10-1_002.jpg GRAPHIC 304907
8 ex10-1_003.jpg GRAPHIC 409866
9 ex10-1_004.jpg GRAPHIC 114279
10 ex10-1_005.jpg GRAPHIC 125872
11 form10-q_1.jpg GRAPHIC 155459
  Complete submission text file 0001493152-22-030942.txt   5366872

Data Files

Seq Description Document Type Size
12 XBRL SCHEMA FILE pcsa-20220930.xsd EX-101.SCH 35095
13 XBRL CALCULATION FILE pcsa-20220930_cal.xml EX-101.CAL 44586
14 XBRL DEFINITION FILE pcsa-20220930_def.xml EX-101.DEF 118366
15 XBRL LABEL FILE pcsa-20220930_lab.xml EX-101.LAB 268840
16 XBRL PRESENTATION FILE pcsa-20220930_pre.xml EX-101.PRE 205587
53 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 418719
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39531 | Film No.: 221368865
SIC: 2834 Pharmaceutical Preparations